Raze Therapeutics Lands $24,000,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ab924553-dd87-4299-bb48-66f79fd62d62 - Date
10/14/2014 - Company Name
Raze Therapeutics - Mailing Address
25 First Street Cambridge, MA 02141 USA - Company Description
Raze Therapeutics is a biotechnology company dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways driving cancer growth and survival. - Website
http://www.razetx.com - Transaction Type
Venture Equity - Transaction Amount
$24,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds from the financing will be used to advance the development of a new class of therapeutics that fight cancer by targeting mitochondrial one-carbon (1C) metabolism – fundamental metabolic pathways necessary for tumors to grow and survive. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
